Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Planned maintenance
A system upgrade is planned for 10/12-2024, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
Refine search result
1 - 11 of 11
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Rows per page
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sort
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
Select
The maximal number of hits you can export is 250. When you want to export more records please use the Create feeds function.
  • 1.
    Fjellström, Sanna
    et al.
    Mid Sweden Univ, Swedish Winter Sport Res Ctr, Dept Hlth Sci, Sundsvall, Sweden.;Mid Sweden Univ, Swedish Winter Sports Res Ctr, Dept Hlth Sci, House D, SE-83125 Östersund, Sweden..
    Hölttä, Jessica
    Mid Sweden Univ, Swedish Winter Sport Res Ctr, Dept Hlth Sci, Sundsvall, Sweden..
    Nordström, Anna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. Mid Sweden Univ, Swedish Winter Sport Res Ctr, Dept Hlth Sci, Sundsvall, Sweden; UiT Arctic Univ Norway, Sch Sports Sci, Tromso, Norway.
    Flygare Wallén, Eva
    Dept Neurobiol Care Sci Soc NVS, Dept Neurobiol Care Sci & Soc NVS, Div Occupat Therapy, Res Grp Hlth Everyday Life People Neurol Disorders, Stockholm, Sweden.;Hlth & Social Care Adm, Östersund, Sweden..
    Lund Ohlsson, Marie
    Mid Sweden Univ, Swedish Winter Sport Res Ctr, Dept Hlth Sci, Sundsvall, Sweden.;Swedish Sch Hlth & Sport Sci GIH, Dept Physiol Nutr & Biomech, Stockholm, Sweden..
    Hansen, Elisabeth
    Mid Sweden Univ, Swedish Winter Sport Res Ctr, Dept Hlth Sci, Sundsvall, Sweden.;Nord Univ, Fac Educ & Arts, Bodo, Norway..
    Increasing physical activity through an adapted web-based exercise program for people with intellectual disabilities: Support staff are crucial for feasibility2024In: JARID: Journal of applied research in intellectual disabilities, ISSN 1360-2322, E-ISSN 1468-3148, Vol. 37, no 2, article id e13191Article in journal (Refereed)
    Abstract [en]

    Background

    People with intellectual disabilities are less physically active and suffer from ill-health more than the general population. Support staff play an important role in the person's life. This study aimed to explore the support staff's experiences regarding the feasibility of adapted web-based exercise for people with intellectual disabilities.

    Method

    Participants with intellectual disabilities living in community-based settings were recruited for a web-based exercise study. Eight semi-structured interviews were carried out with their support staff before and after the intervention period.

    Results

    The main theme, ‘Support staff are crucial for feasibility’ encompasses the importance of communication, structure, and motivation in improving physical activity for people with intellectual disabilities.

    Conclusion

    The experiences of support staff, indicate that a web-based exercise program is feasible for the target group, and one way to overcome challenges for PA, where the role of the staff is crucial.

    Download full text (pdf)
    fulltext
  • 2.
    Kanis, J. A.
    et al.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia.;Univ Sheffield, Ctr Metab Bone Dis, Sheffield, England..
    Johansson, H.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia.;Univ Gothenburg, Inst Med, Sahlgrenska Osteoporosis Ctr, Gothenburg, Sweden..
    McCloskey, E. , V
    Liu, E.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia..
    Akesson, K. E.
    Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Lund, Sweden.;Skane Univ Hosp, Dept Orthoped, Malmö, Sweden..
    Anderson, F. A.
    Univ Massachusetts, Med Sch, Ctr Outcomes Res, GLOW Coordinating Ctr, Worcester, MA USA..
    Azagra, R.
    Autonomous Univ Barcelona, Dept Med, Barcelona, Spain.;Catalan Inst Hlth, Hlth Ctr Badia Valles, Barcelona, Spain.;PRECIOSA Fdn invest, Barbera Valles, Barcelona, Spain..
    Bager, C. L.
    Nord Biosci AS, Herlev, Denmark..
    Beaudart, C.
    Univ Liege, Div Publ Hlth Epidemiol & Hlth Econ, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium.;Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands..
    Bischoff-Ferrari, H. A.
    Univ Zurich Hosp, Dept Aging Med & Aging Res, Zurich, Switzerland.;Univ Zurich, Zurich, Switzerland.;Univ Zurich & City Hosp, Ctr Aging & Mobil, Zurich, Switzerland..
    Biver, E.
    Univ Hosp Geneva, Dept Med, Div Bone Dis, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland..
    Bruyere, O.
    Univ Liege, Div Publ Hlth Epidemiol & Hlth Econ, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium..
    Cauley, J. A.
    Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA..
    Center, J. R.
    Garvan Inst Med Res, Skeletal Dis Program, Sydney, NSW, Australia.;Univ New South Wales Sydney, Sch Med & Hlth, St Vincents Clin Sch, Sydney, NSW, Australia.;Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia..
    Chapurlat, R.
    Univ Claude Bernard Lyon1, INSERM UMR 1033, Hop Edouard Herriot, Lyon, France..
    Christiansen, C.
    Nord Biosci AS, Herlev, Denmark..
    Cooper, C.
    Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England.;Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.;Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.;Univ Oxford, NIHR Oxford Biomed Res Unit, Oxford, England..
    Crandall, C. J.
    Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA..
    Cummings, S. R.
    San Francisco Coordinating Ctr, Calif Pacific Med Ctr Res Inst, San Francisco, CA USA..
    da Silva, J. A. P.
    Univ Coimbra, Coimbra Inst Clin & Biomed Res, Fac Med, Coimbra, Portugal.;Ctr Hosp & Univ Coimbra, Dept Rheumatol, Coimbra, Portugal..
    Dawson-Hughes, B.
    Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Bone Metab Lab, Boston, MA USA..
    Diez-Perez, A.
    Autonomous Univ Barcelona, Hosp Mar, Dept Internal Med, Barcelona, Spain.;Autonomous Univ Barcelona, CIBERFES, Barcelona, Spain..
    Dufour, A. B.
    Marcus Inst Aging Res, Hebrew Senior Life, Boston, MA USA.;Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA..
    Eisman, J. A.
    Garvan Inst Med Res, Skeletal Dis Program, Sydney, NSW, Australia.;Univ New South Wales Sydney, Sch Med & Hlth, St Vincents Clin Sch, Sydney, NSW, Australia.;Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia..
    Elders, P. J. M.
    Harvard Med Sch, Boston, MA USA..
    Ferrari, S.
    Univ Hosp Geneva, Dept Med, Div Bone Dis, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland..
    Fujita, Y.
    Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Locat AMC, Petra JM Elders Dept Gen Practice, Amsterdam, Netherlands..
    Fujiwara, S.
    Kindai Univ, Ctr Med Educ & Clin Training, Fac Med, Osaka, Japan..
    Glueer, C. -c.
    Yasuda Womens Univ, Dept Pharm, Hiroshima, Japan..
    Goldshtein, I.
    Univ Kiel, Univ Med Ctr Schleswig Holstein Kiel, Sect Biomed Imaging, Mol Imaging North Competence Ctr,Dept Radiol & Ne, Kiel, Germany.;Maccabitech Inst Res & Innovat, Maccabi Healthcare Serv, Tel Aviv, Israel..
    Goltzman, D.
    Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Sackler Fac Med, Tel Aviv, Israel..
    Gudnason, V.
    McGill Univ, Dept Med, Montreal, PQ, Canada.;McGill Univ, Hlth Ctr, Montreal, PQ, Canada.;Iceland Heart Assoc, Kopavogur, Iceland.;Univ Iceland, Reykjavik, Iceland..
    Hall, J.
    Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland..
    Hans, D.
    Lausanne Univ Hosp CHUV, Bone & Joint Dept, Interdisciplinary Ctr Bone Dis, Lausanne, Switzerland.;Univ Lausanne, Lausanne, Switzerland..
    Hoff, M.
    Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway.;St Olavs Hosp, Dept Rheumatol, Trondheim, Norway..
    Hollick, R. J.
    Univ Aberdeen, Epidemiol Grp, Aberdeen Ctr Arthrit & Musculoskeletal Hlth, Aberdeen, Scotland..
    Huisman, M.
    Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Data Sci, Amsterdam, Netherlands.;Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands..
    Iki, M.
    Kindai Univ, Dept Publ Hlth, Fac Med, Osaka, Japan..
    Ish-Shalom, S.
    Elisha Hosp, Endocrine Clin, Haifa, Israel..
    Jones, G.
    Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia..
    Karlsson, M. K.
    Khosla, S.
    Mayo Clin, Coll Med, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA.;Mayo Clin, Coll Med, Div Endocrinol, Rochester, MN USA..
    Kiel, D. P.
    Marcus Inst Aging Res, Hebrew Senior Life, Boston, MA USA.;Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA..
    Koh, W. -p.
    Natl Univ Singapore, Yong Loo Lin Sch Med, Healthy Longev Translat Res Programme, Singapore, Singapore.;Agcy Sci Technol & Res STAR, Singapore Inst Clin Sci, Singapore, Singapore..
    Koromani, F.
    Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.;Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands..
    Kotowicz, M. A.
    Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia.;Barwon Hlth, Geelong, Vic, Australia.;Univ Melbourne, Western Hlth, Dept Med, St Albans, Vic, Australia..
    Kroger, H.
    Kuopio Univ Hosp, Dept Orthoped & Traumatol, Kuopio, Finland.;Univ Eastern Finland, Kuopio Musculoskeletal Res Unit, Kuopio, Finland..
    Kwok, T.
    Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Hong Kong, Peoples R China.;Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Fac Med, Hong Kong, Peoples R China..
    Lamy, O.
    Lausanne Univ Hosp, Ctr Bone Dis, Lausanne, Switzerland.;Lausanne Univ Hosp, Serv Internal Med, Lausanne, Switzerland..
    Langhammer, A.
    Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway..
    Larijani, B.
    Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran..
    Lippuner, K.
    Univ Bern, Univ Hosp Bern, Dept Osteoporosis, Bern, Switzerland..
    Mellstrom, D.
    Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden.;Sahlgrenska Univ Hosp Mölndal, Geriatr Med, Mölndal, Sweden..
    Merlijn, T.
    Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Locat AMC, Dept Gen Practice, Amsterdam, Netherlands..
    Nordström, Anna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway.;Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Östersund, Sweden..
    Nordström, Peter
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    O'Neill, T. W.
    Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res Manchester Biomed Res Ctr, Manchester, Lancs, England.;Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England..
    Obermayer-Pietsch, B.
    Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria.;Ctr Biomarker Res Med, Graz, Austria..
    Ohlsson, C.
    Univ Gothenburg, Sahlgrenska Acad, Inst Med, Sahlgrenska Osteoporosis Ctr,Dept Internal Med &, Gothenburg, Sweden.;Sahlgrens Univ Hosp, Dept Drug Treatment, Region Vastra Gotaland, Gothenburg, Sweden..
    Orwoll, E. S.
    Oregon Hlth & Sci Univ, Dept Med, Portland, OR USA..
    Pasco, J. A.
    Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia.;Barwon Hlth, Geelong, Vic, Australia.;Univ Melbourne, Western Hlth, Dept Med, St Albans, Vic, Australia.;Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Australia..
    Rivadeneira, F.
    Erasmus MC, Dept Internal Med, Rotterdam, Netherlands..
    Schott, A. -M
    Shiroma, E. J.
    Natl Inst Aging, Lab Epidemiol & Populat Sci, Baltimore, MD USA..
    Siggeirsdottir, K.
    McGill Univ, Dept Med, Montreal, PQ, Canada.;McGill Univ, Hlth Ctr, Montreal, PQ, Canada.;Janus Rehabil, Reykjavik, Iceland..
    Simonsick, E. M.
    Natl Inst Aging Intramural Res Program, Translat Gerontol Branch, Baltimore, MD USA..
    Sornay-Rendu, E.
    Univ Lyon, INSERM UMR 1033, Hop Edouard Herriot, Lyon, France..
    Sund, R.
    Swart, K. M. A.
    Harvard Med Sch, Boston, MA USA.;PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands..
    Szulc, P.
    Univ Lyon, INSERM UMR 1033, Hop Edouard Herriot, Lyon, France..
    Tamaki, J.
    Osaka Med & Pharmaceut Univ, Dept Hyg & Publ Hlth, Fac Med, Educ Fdn, Osaka, Japan..
    Torgerson, D. J.
    Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England..
    van Schoor, N. M.
    Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Data Sci, Amsterdam, Netherlands..
    van Staa, T. P.
    Univ Manchester, Sch Hlth Sci, Ctr Hlth Informat, Fac Biol Med & Hlth, Manchester, Lancs, England..
    Vila, J.
    Hosp Mar Med Res Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Stat Support Unit, Barcelona, Spain..
    Wareham, N. J.
    Univ Cambridge, MRC Epidemiol Unit, Cambridge, England..
    Wright, N. C.
    Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA..
    Yoshimura, N.
    Tokyo Univ Hosp, Dept Prevent Med Locomot Organ Disorders, Tokyo, Japan..
    Zillikens, M. C.
    Zwart, M.
    PRECIOSA Fdn invest, Barbera Valles, Barcelona, Spain.;Catalan Inst Hlth, Hlth Ctr Can Gibert Pla, Girona, Spain.;Univ Girona, Dept Med Sci, Girona, Spain.;Inst Univ dInvest Atencio Primaria Jordi Gol, Unitat Suport Recerca Girona, GROIMAP GROICAP Res grp, Girona, Spain..
    Vandenput, L.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia..
    Harvey, N. C.
    Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England.;Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.;Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England..
    Lorentzon, M.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia..
    Leslie, W. D.
    Univ Manitoba, Dept Med, Winnipeg, MB, Canada..
    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX2023In: Osteoporosis International, ISSN 0937-941X, E-ISSN 1433-2965, Vol. 34, no 12, p. 2027-2045Article in journal (Refereed)
    Abstract [en]

    A large international meta-analysis using primary data from 64 cohorts has quantified the increased risk of fracture associated with a previous history of fracture for future use in FRAX.IntroductionThe aim of this study was to quantify the fracture risk associated with a prior fracture on an international basis and to explore the relationship of this risk with age, sex, time since baseline and bone mineral density (BMD).MethodsWe studied 665,971 men and 1,438,535 women from 64 cohorts in 32 countries followed for a total of 19.5 million person-years. The effect of a prior history of fracture on the risk of any clinical fracture, any osteoporotic fracture, major osteoporotic fracture, and hip fracture alone was examined using an extended Poisson model in each cohort. Covariates examined were age, sex, BMD, and duration of follow-up. The results of the different studies were merged by using the weighted & beta;-coefficients.ResultsA previous fracture history, compared with individuals without a prior fracture, was associated with a significantly increased risk of any clinical fracture (hazard ratio, HR = 1.88; 95% CI = 1.72-2.07). The risk ratio was similar for the outcome of osteoporotic fracture (HR = 1.87; 95% CI = 1.69-2.07), major osteoporotic fracture (HR = 1.83; 95% CI = 1.63-2.06), or for hip fracture (HR = 1.82; 95% CI = 1.62-2.06). There was no significant difference in risk ratio between men and women. Subsequent fracture risk was marginally downward adjusted when account was taken of BMD. Low BMD explained a minority of the risk for any clinical fracture (14%), osteoporotic fracture (17%), and for hip fracture (33%). The risk ratio for all fracture outcomes related to prior fracture decreased significantly with adjustment for age and time since baseline examination.ConclusionA previous history of fracture confers an increased risk of fracture of substantial importance beyond that explained by BMD. The effect is similar in men and women. Its quantitation on an international basis permits the more accurate use of this risk factor in case finding strategies.

  • 3.
    Klang, Andrea
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine.
    Molero, Yasmina
    Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.;Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden..
    Lichtenstein, Paul
    Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden..
    Larsson, Henrik
    Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.;Örebro Univ, Dept Med Sci, Örebro, Sweden..
    D'Onofrio, Brian Matthew
    Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.;Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA..
    Marklund, Niklas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Neurosurgery. Lund Univ, Skane Univ Hosp, Neurosurg, Dept Clin Sci Lund, Lund, Sweden..
    Oldenburg, Christian
    Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden..
    Rostami, Elham
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Neurosurgery. Karolinska Inst, Dept Neurosci, Stockholm, Sweden.;Lund Univ, Skane Univ Hosp, Neurosurg, Dept Clin Sci Lund, Lund, Sweden..
    Access to Rehabilitation After Hospitalization for Traumatic Brain Injury: A National Longitudinal Cohort Study in Sweden2023In: Neurorehabilitation and Neural Repair, ISSN 1545-9683, E-ISSN 1552-6844, Vol. 37, no 11-12, p. 763-774Article in journal (Refereed)
    Abstract [en]

    Background: Rehabilitation is suggested to improve outcomes following traumatic brain injury (TBI), however, the extent of access to rehabilitation among TBI patients remains unclear. Objective To examine the level of access to rehabilitation after TBI, and its association with health and sociodemographic factors.

    Method: We conducted a longitudinal cohort study using Swedish nationwide healthcare and sociodemographic registers. We identified 15880 TBI patients >= 18years hospitalized >= 3days from 2008 to 2012 who were stratified into 3 severity groups; grade I (n=1366; most severe), grade II (n=5228), and grade III (n=9268; least severe). We examined registered contacts with specialized rehabilitation or geriatric care (for patients >= 65years) during the hospital stay, and/or within 1year post-discharge. We performed a generalized linear model analysis to estimate the risk ratio (RR) for receiving specialized rehabilitation or geriatric care after a TBI based on sociodemographic and health factors.

    Results: Among TBI patients, 46/35% (grade I), 14/40% (grade II), and 5/18% (grade III) received specialized rehabilitation or geriatric care, respectively. Being currently employed or studying was positively associated (RR 1.7, 2.3), while living outside of a city area was negatively associated (RR 0.36, 0.79) with receiving specialized rehabilitation or geriatric care. Older age and a prior substance use disorder were negatively associated with receiving specialized rehabilitation (RR 0.51 and 0.81).

    Conclusion: Our results suggest insufficient and unequal access to rehabilitation for TBI patients, highlighting the importance of organizing and standardizing post-TBI rehabilitation to meet the needs of patients, regardless of their age, socioeconomic status, or living area.

    Download full text (pdf)
    fulltext
  • 4.
    Kyhlbäck, Maria
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Neuroscience, Rehabilitation Medicine.
    Söderlund, Anne
    Thierfelder, Tomas
    Frykberg, Gunilla
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine.
    Physiotherapy treatment of the diabetic shoulder: health-related quality of life and measures of shoulder function regarding patients with type 1 diabetes2019In: Disability and Rehabilitation, ISSN 0963-8288, E-ISSN 1464-5165, Vol. 41, no 12, p. 1435-1442Article in journal (Refereed)
    Abstract [en]

    Purpose: The aim of this study was to investigate how health-related quality of life (HRQoL) and functional shoulder range of motion are affected among patients with diabetes with shoulder problems, treated with a specific physiotherapy programme. A further aim was to investigate how health-related quality of life, functional shoulder range of motion, pain intensity, and shoulder function correlate within the group of patients after the treatment period.

    Method: A pre–post treatment design was applied for a study group of ten patients with type 1 diabetes and shoulder problems. The physiotherapy treatment consisted of exercises promoting enhanced microcirculation in the shoulder tissues, optimal shoulder co-ordination,  and muscle relaxation. The Short Form-36 (SF-36), shoulder range of motion measures, the Shoulder Rating Scale – Swedish version, and pain intensity measures were used. The results regarding SF-36 were compared with the results of a control group of patients having either type 1 or type 2 diabetes and shoulder problems that did not receive any specific physiotherapy treatment.

    Results: As a potential result of physiotherapy training, a significant change towards higher scores was observed in the physical component summary (PCS) measure of SF-36. There was a significant improvement regarding PCS in the study group as compared with the control group. There were negative correlations between the four aspects of pain intensity and PCS and Shoulder Rating Scale – Swedish version, respectively, but a positive correlation between PCS and Shoulder Rating Scale – Swedish version. “Handraising” and “hand-behind-back” were significantly improved, and proved to be positively correlated with Shoulder Rating Scale – Swedish version.

    Conclusions: The results of this study indicate that patients with type 1 diabetes and shoulder problems,treated with a specific physiotherapy programme, may improve with respect to physical aspects of healthrelated quality of life, and partially regain their range of motion in the shoulder joint. Based on these results, the associated treatment protocol may be recommended for physiotherapy treatment in such patients.

  • 5.
    Nordström, Anna
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway..
    Nordström, Peter
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Impaired Balance Predicts Cardiovascular Disease in 70-Year-Old Individuals-An Observational Study From the Healthy Aging Initiative2024In: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, E-ISSN 2047-9980, Vol. 13, no 19, article id e035073Article in journal (Refereed)
    Abstract [en]

    Background: Limited research has explored balance problems as a prospective risk factor for cardiovascular disease (CVD). This study aimed to characterize the association between balance measures and the risk of incident CVD in a population of 70-year-olds.

    Methods and Results: From 2012 to 2022 a cohort of 4927 older individuals who were CVD free underwent balance assessments using a balance board. Measurements included lateral and anterior-posterior sway, along with a safety limit of stability in a subcohort (N=2782). Time to first hospitalization for CVD, encompassing stroke, myocardial infarction, or angina pectoris was the primary outcome. Multivariable regression models assessed associations between balance parameters and CVD risk. Over a mean follow-up of 4.9 years, 320 individuals were hospitalized for CVD. In a balance test with eyes open, increased lateral sway at baseline was associated with a higher risk of CVD (hazard ratio [HR], 1.014 [95% CI, 1.004-1.025], P=0.005, per mm increased sway), after adjustment for traditional risk factors for CVD. Similarly, individuals with CVD during follow-up exhibited higher lateral sway with eyes closed at baseline (HR, 1.015 [95% CI, 1.005-1.025], P=0.002, per mm increased sway), after multivariable adjustment. The 4 strongest independent predictors of CVD included lateral sway and were associated with a population attributable fraction of 61% (95% CI, 54-68).

    Conclusions: In community-dwelling 70-year-olds, impaired lateral balance was an independent predictor of later CVD, after adjustment for traditional risk factors. This may suggest that position balance could be used as an early risk marker for underlying atherosclerotic disease.

    Download full text (pdf)
    fulltext
  • 6.
    Nordström, Peter
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Ahlqvist, Viktor H.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Aarhus Univ, Dept Biomed, Aarhus, Denmark.;Karolinska Inst, Inst Environm Med, Stockholm, Sweden..
    Ballin, Marcel
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Ctr Epidemiol & Community Med, Stockholm, Stockholm, Sweden..
    Nordström, Anna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. Arctic Univ Norway, UiT, Sch Sport Sci, Tromso, Norway..
    A novel clinical prediction model for hip fractures: a development and validation study in the total population of Sweden2024In: eClinicalMedicine, E-ISSN 2589-5370, Vol. 77, article id 102877Article in journal (Refereed)
    Abstract [en]

    Background Low bone density and osteoporosis are indications for bone-specific fi c treatment. However, given the limited availability of bone density data in clinical practice and the fact that most patients with hip fracture do not have osteoporosis, accurate prediction of hip fracture risk in the absence of bone density data would be crucial. Methods This development and validation study included the entire Swedish population aged 50 years or older in 2005 (N = 3,340,977) and was conducted by cross-linking data from nationwide registers. Potential predictive variables included diagnoses, prescription medications, familial factors, frailty-related factors, and socioeconomic factors. The primary endpoint was the 5-year risk of hip fracture. Fracture prediction algorithms were developed and validated using multivariable models. Model performance and validation was also examined in a sub cohort restricted to 504,431 individuals with non-Swedish background. Findings During a total follow-up of 15.2 million person-years, 87,089 individuals suffered a hip fracture within 5 years. In the fi nal prediction model, 19 variables were associated with a population attributable fraction of 93.9% (95% CI, 93.7-94.1) - 94.1) in women and 92.7% (95% CI, 92.2-93.0) - 93.0) in men. The strongest predictor, besides old age, was the use of homemaker service, with a 5-year risk of hip fracture of 7.8% in women and 4.7% in men. The diagnoses most strongly predicting the 5-year risk of hip fracture was Parkinson's ' s disease (6.8% in women, 4.6% in men) and dementia (6.1% in women, 3.6% in men). Validation of the prediction model suggested that the optimal threshold for treatment with bone-specific fi c agents was an estimated 5-year hip fracture risk of 3%. Assuming a threshold of 3% and a 30% relative risk reduction from bone-specific fi c treatment, the number needed to treat to prevent one hip fracture was estimated to 36 in women and 52 in men. Similar results were obtained in the sub cohort with non-Swedish background. Interpretation A clinical prediction model developed and validated in the total Swedish population could predict the risk of hip fractures with high precision even in absence of data on bone density. The model was associated with a population attributable fraction for hip fracture of more than 90%, and the strongest predictor besides old age was the use of homemaker service, which likely reflect fl ect frailty. Based on the model, individuals with an estimated 5-year risk of hip fracture of at least 3% could be considered for bone-specific fi c treatment. Funding None. Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 2024;77: Published https://doi.org/10. 1016/j.eclinm.2024. 102877

    Download full text (pdf)
    fulltext
  • 7.
    Pinto, Susana
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. Rehabiliteringsmedicin, Akademiska sjukhuset, Uppsala, Sweden;Translational Clinical Physiology Unit, Instituto de Medicina Molecular – Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
    Determining the need for caregiver support using ALSFRS-R and its limitations2023In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ISSN 2167-8421, E-ISSN 2167-9223, Vol. 24, no 1-2, p. 155-156Article in journal (Refereed)
  • 8.
    Pinto, Susana
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. Institute of Physiology, Instituto de Medicina Molecular João Lobo Antunes – Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
    Gromicho, Marta
    Institute of Physiology, Instituto de Medicina Molecular João Lobo Antunes – Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
    Oliveira Santos, Miguel
    Institute of Physiology, Instituto de Medicina Molecular João Lobo Antunes – Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.
    Swash, Michael
    Institute of Physiology, Instituto de Medicina Molecular João Lobo Antunes – Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;Departments of Neurology and Neuroscience, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom.
    de Carvalho, Mamede
    Institute of Physiology, Instituto de Medicina Molecular João Lobo Antunes – Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.
    Respiratory onset in amyotrophic lateral sclerosis: clinical features and spreading pattern2023In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, ISSN 2167-8421, E-ISSN 2167-9223, Vol. 24, no 1-2, p. 40-44Article in journal (Refereed)
    Abstract [en]

    Objective To describe the clinical features and progression of patients with respiratory onset amyotrophic lateral sclerosis (ALS).

    Methods: We analyzed the clinical features, including respiratory tests, functional score, noninvasive ventilation (NIV) time and survival of ALS patients with respiratory-onset in our database consisting of 1688 patients. In a subset of 625 ALS patients we analyzed the spreading pattern to other bodily regions.

    Results: We included 1579 patients with ALS. Sixty-three patients (4%) presented respiratory-onset (79.4% men, mean onset-age 67.7 +/- 8.9yrs). All had predominant LMN involvement, and significant weight loss (>10%) was identified in 38.9%. The respiratory tests were abnormal in these respiratory-onset patients (p < 0.001). ALSFRS-R respiratory subscore was lower in this population (p < 0.001). NIV was adapted in 84.1%, sooner than in the larger group of ALS patients (p < 0.001), and survival from disease onset was shorter (p < 0.001). Respiratory-onset was a predictor of time to NIV (X-2=42.0, p < 0.001) and of survival (X-2=7.1, p = 0.008). The spreading pattern was studied in 18 patients with isolated respiratory-onset. The progression interval to the 2nd region was 4.7 +/- 5.7mo and to a 3rd region 6.1 +/- 8.7mo. Different patterns of spread had no impact on survival.

    Conclusions: This phenotype is typically seen in emaciated older men with predominant lower motor neuron involvement, and is associated with diaphragm paresis and central respiratory involvement. NIV adaptation is rapid but total survival is shorter than in the other patients. Spreading pattern did not affect time to NIV adaptation or total survival, as NIV support is a modifying treatment in the course of ALS.

  • 9.
    Pinto, Susana
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. Univ Lisbon, Inst Physiol, Ctr Estudos Egas Moniz, Inst Med Mol Joao Lobo Antunes,Fac Med, Lisbon, Portugal..
    Santos, Miguel Oliveira
    Univ Lisbon, Inst Physiol, Ctr Estudos Egas Moniz, Inst Med Mol Joao Lobo Antunes,Fac Med, Lisbon, Portugal.;Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Neurosci & Mental Hlth, Lisbon, Portugal..
    Gromicho, Marta
    Univ Lisbon, Inst Physiol, Ctr Estudos Egas Moniz, Inst Med Mol Joao Lobo Antunes,Fac Med, Lisbon, Portugal..
    Swash, Michael
    Univ Lisbon, Inst Physiol, Ctr Estudos Egas Moniz, Inst Med Mol Joao Lobo Antunes,Fac Med, Lisbon, Portugal.;Queen Mary Univ London, Barts & London Sch Med, Dept Neurol & Neurosci, London, England..
    de Carvalho, Mamede
    Univ Lisbon, Inst Physiol, Ctr Estudos Egas Moniz, Inst Med Mol Joao Lobo Antunes,Fac Med, Lisbon, Portugal.;Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Neurosci & Mental Hlth, Lisbon, Portugal..
    Respiratory phenotypes in amyotrophic lateral sclerosis as determined by respiratory questions on the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised and their relation to respiratory tests2023In: European Journal of Neurology, ISSN 1351-5101, E-ISSN 1468-1331, Vol. 30, no 6, p. 1594-1599Article, review/survey (Refereed)
    Abstract [en]

    Background and purpose Respiratory insufficiency and its complications are the main cause of death in amyotrophic lateral sclerosis (ALS). Respiratory symptoms are scored in questions Q10 (dyspnoea) and Q11 (orthopnoea) of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R). The association of respiratory test alterations with respiratory symptoms is unclear. Methods Patients with ALS and progressive muscular atrophy were included. We retrospectively recorded demographic data, ALSFRS-R, forced vital capacity (FVC), maximal inspiratory (MIP) and expiratory (MEP) pressures, mouth occlusion pressure at 100 ms, nocturnal oximetry (SpO(2)mean), arterial blood gases, and phrenic nerve amplitude (PhrenAmpl). Three groups were categorized: G1, normal Q10 and Q11; G2, abnormal Q10; and G3, abnormal Q10 and Q11 or only abnormal Q11. A binary logistic regression model explored independent predictors. Results We included 276 patients (153 men, onset age = 62.6 +/- 11.0 years, disease duration = 13.0 +/- 9.6 months, spinal onset in 182) with mean survival of 40.1 +/- 26.0 months. Gender, onset region, and disease duration were similar in G1 (n = 149), G2 (n = 78), and G3 (n = 49). Time to noninvasive ventilation (NIV) was shorter in G3 (p < 0.001), but survival was similar. ALSFRS-R subscores were significantly different (G1>G2>G3, p < 0.001), except for lower limb subscore (p = 0.077). G2 and G3 patients were older than G1 (p < 0.001), and had lower FVC, MIP, MEP, PhrenAmpl, and SpO(2)mean. Independent predictors for G2 were MIP and SpO(2)mean; for G3, the only independent predictor was PhrenAmpl. Conclusions These three distinct ALS phenotypic respiratory categories represent progressive stages of ventilatory dysfunction, supporting ALSFRS-R clinical relevance. Orthopnoea is a severe symptom that should prompt NIV, phrenic nerve response being an independent predictor. Early NIV promotes similar survival for G2 and G3.

    Download full text (pdf)
    fulltext
  • 10.
    Trolle, Carl
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. Uppsala Univ Hosp, Dept Med Sci, Rehabil Med, S-75185 Uppsala, Sweden.
    Han, Yilin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Genomics and Neurobiology.
    Jagalur Mutt, Shivaprakash
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology. Uppsala University, Science for Life Laboratory, SciLifeLab.
    Christoffersson, Gustaf
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology. Uppsala University, Science for Life Laboratory, SciLifeLab.
    Kozlova, Elena N.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Genomics and Neurobiology.
    Boundary cap neural crest stem cells promote angiogenesis after transplantation to avulsed dorsal roots in mice and induce migration of endothelial cells in 3D printed scaffolds2024In: Neuroscience Letters, ISSN 0304-3940, E-ISSN 1872-7972, Vol. 826, article id 137724Article in journal (Refereed)
    Abstract [en]

    Dorsal root avulsion injuries lead to loss of sensation and to reorganization of blood vessels (BVs) in the injured area. The inability of injured sensory axons to re-enter the spinal cord results in permanent loss of sensation, and often also leads to the development of neuropathic pain. Approaches that restore connection between peripheral sensory axons and their CNS targets are thus urgently need. Previous research has shown that sensory axons from peripherally grafted human sensory neurons are able to enter the spinal cord by growing along BVs which penetrate the CNS from the spinal cord surface. In this study we analysed the distribution of BVs after avulsion injury and how their pattern is affected by implantation at the injury site of boundary cap neural crest stem cells (bNCSCs), a transient cluster of cells, which are located at the boundary between the spinal cord and peripheral nervous system and assist the growth of sensory axons from periphery into the spinal cord during development. The superficial dorsal spinal cord vasculature was examined using intravital microscopy and intravascular BV labelling. bNCSC transplantation increased vascular volume in a non-dose responsive manner, whereas dorsal root avulsion alone did not decrease the vascular volume. To determine whether bNCSC are endowed with angiogenic properties we prepared 3D printed scaffolds, containing bNCSCs together with rings prepared from mouse aorta. We show that bNCSC do induce migration and assembly of endothelial cells in this system. These findings suggest that bNCSC transplant can promote vascularization in vivo and contribute to BV formation in 3D printed scaffolds.

    Download full text (pdf)
    fulltext
  • 11.
    Vandenput, Liesbeth
    et al.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia..
    Johansson, Helena
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia.;Univ Sheffield, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England.;Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Osteoporosis Ctr, Dept Internal Med & Clin Nutr,Inst Med, Gothenburg, Sweden..
    McCloskey, Eugene V.
    Univ Sheffield, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England.;Univ Sheffield, MRC & Arthrit Res UK Ctr Integrated Res Musculosk, Mellanby Ctr Musculoskeletal Res, Sheffield, S Yorkshire, England..
    Liu, Enwu
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia..
    Schini, Marian
    Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, S Yorkshire, England..
    Åkesson, Kristina E.
    Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Lund, Sweden.;Skane Univ Hosp, Dept Orthoped, Malmö, Sweden..
    Anderson, Fred A.
    Univ Massachusetts, GLOW Coordinating Ctr, Ctr Outcomes Res, Med Sch, Worcester, MA USA..
    Azagra, Rafael
    Autonomous Univ Barcelona, Dept Med, Barcelona, Spain.;Catalan Inst Hlth, Hlth Ctr Badia del Valles, Barcelona, Spain.;Inst Univ Invest Atencio Primaria Jordi Gol, GROIMAP Res Grp, Unitat Suport Recerca Metropolitana Nord, Barcelona, Spain.;PRECIOSA Fdn Invest, Barcelona, Spain..
    Bager, Cecilie L.
    Nord Biosci AS, Herlev, Denmark..
    Beaudart, Charlotte
    Univ Liege, Div Publ Hlth Epidemiol & Hlth Econ, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium.;Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands..
    Bischoff-Ferrari, Heike A.
    Univ Hosp, Dept Aging Med & Aging Res, Zurich, Switzerland.;Univ Zurich, Zurich, Switzerland.;Univ Zurich, Ctr Aging & Mobil, Zurich, Switzerland.;City Hosp, Zurich, Switzerland..
    Biver, Emmanuel
    Geneva Univ Hosp, Div Bone Dis, Dept Med, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland..
    Bruyère, Olivier
    Univ Liege, Div Publ Hlth Epidemiol & Hlth Econ, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium..
    Cauley, Jane A.
    Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA..
    Center, Jacqueline R.
    Garvan Inst Med Res, Skeletal Dis Program, Sydney, NSW, Australia.;Univ New South Wales Sydney, Sch Med & Hlth, St Vincents Clin Sch, Sydney, NSW, Australia.;Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia..
    Chapurlat, Roland
    Univ Claude Bernard Lyon1, Hop Edouard Herriot, INSERM, UMR 1033, Lyon, France..
    Christiansen, Claus
    Nord Biosci AS, Herlev, Denmark..
    Cooper, Cyrus
    Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England.;Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.;Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.;Univ Oxford, NIHR Oxford Biomed Res Unit, Oxford, England..
    Crandall, Carolyn J.
    Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA..
    Cummings, Steven R.
    Calif Pacific Med Ctr, San Francisco Coordinating Ctr, Res Inst, San Francisco, CA USA..
    da Silva, José A. P.
    Univ Coimbra, Coimbra Inst Clin & Biomed Res, Fac Med, Coimbra, Portugal.;Ctr Hosp E Univ Coimbra, Rheumatol Dept, Coimbra, Portugal..
    Dawson-Hughes, Bess
    Tufts Univ, Bone Metab Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA..
    Diez-Perez, Adolfo
    Hosp del Mar, Dept Internal Med, Barcelona, Spain.;Autonomous Univ Barcelona, CIBERFES, Barcelona, Spain..
    Dufour, Alyssa B.
    Hebrew SeniorLife, Marcus Inst Aging Res, Boston, MA USA.;Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.;Harvard Med Sch, Boston, MA 02115 USA..
    Eisman, John A.
    Garvan Inst Med Res, Skeletal Dis Program, Sydney, NSW, Australia.;Univ New South Wales Sydney, Sch Med & Hlth, St Vincents Clin Sch, Sydney, NSW, Australia.;Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia..
    Elders, Petra J. M.
    Amsterdam UMC, Locat AMC, Amsterdam Publ Hlth Res Inst, Dept Gen Practice, Amsterdam, Netherlands..
    Ferrari, Serge
    Geneva Univ Hosp, Div Bone Dis, Dept Med, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland..
    Fujita, Yuki
    Kindai Univ, Ctr Med Educ & Clin Training, Fac Med, Osaka, Japan..
    Fujiwara, Saeko
    Yasuda Womens Univ, Dept Pharm, Hiroshima, Japan..
    Glüer, Claus-Christian
    Univ Kiel, Univ Med Ctr Schleswig Holstein Kiel, Mol Imaging North Competence Ctr, Dept Radiol & Neuroradiol,Sect Biomed Imaging, Kiel, Germany..
    Goldshtein, Inbal
    Maccabi Healthcare Serv, Maccabitech Inst Res & Innovat, Tel Aviv, Israel.;Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Sackler Fac Med, Tel Aviv, Israel..
    Goltzman, David
    McGill Univ, Dept Med, Montreal, PQ, Canada.;McGill Univ Hlth Ctr, Montreal, PQ, Canada..
    Gudnason, Vilmundur
    Iceland Heart Assoc, Kopavogur, Iceland.;Univ Iceland, Reykjavik, Iceland..
    Hall, Jill
    Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland..
    Hans, Didier
    Lausanne Univ Hosp CHUV, Bone & Joint Dept, Interdisciplinary Ctr Bone Dis, Lausanne, Switzerland.;Univ Lausanne, Lausanne, Switzerland..
    Hoff, Mari
    Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway.;St Olavs Hosp, Dept Rheumatol, Trondheim, Norway..
    Hollick, Rosemary J.
    Univ Aberdeen, Epidemiol Grp, Aberdeen Ctr Arthrit & Musculoskeletal Hlth, Aberdeen, Scotland..
    Huisman, Martijn
    Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Data Sci, Amsterdam, Netherlands.;Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands..
    Iki, Masayuki
    Kindai Univ, Fac Med, Dept Publ Hlth, Osaka, Japan..
    Ish-Shalom, Sophia
    Elisha Hosp, Endocrine Clin, Haifa, Israel..
    Jones, Graeme
    Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia..
    Karlsson, Magnus K.
    Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Lund, Sweden.;Skane Univ Hosp, Dept Orthopaed, Malmö, Sweden..
    Khosla, Sundeep
    Mayo Clin, Coll Med, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA.;Mayo Clin, Coll Med, Div Endocrinol, Rochester, MN USA..
    Kiel, Douglas P.
    Hebrew SeniorLife, Marcus Inst Aging Res, Boston, MA USA.;Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.;Harvard Med Sch, Boston, MA 02115 USA..
    Koh, Woon-Puay
    Natl Univ Singapore, Yong Loo Lin Sch Med, Hlth Longev Translat Res Programme, Singapore, Singapore.;ASTAR, Singapore Inst Clin Sci, Singapore, Singapore..
    Koromani, Fjorda
    Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.;Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands..
    Kotowicz, Mark A.
    Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia.;Barwon Hlth, Geelong, Vic, Australia.;Univ Melbourne, Dept Med Western Hlth, St Albans, Vic, Australia..
    Kröger, Heikki
    Kuopio Univ Hosp, Dept Orthoped & Traumatol, Kuopio, Finland.;Univ Eastern Finland, Kuopio Musculoskeletal Res Unit, Kuopio, Finland..
    Kwok, Timothy
    Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Hong Kong, Peoples R China.;Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Fac Med, Hong Kong, Peoples R China..
    Lamy, Olivier
    Lausanne Univ Hosp, Ctr Bone Dis, Lausanne, Switzerland.;Lausanne Univ Hosp, Serv Internal Med, Lausanne, Switzerland..
    Langhammer, Arnulf
    Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, HUNT Res Ctr, Fac Med & Hlth Sci, Trondheim, Norway..
    Larijani, Bagher
    Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran..
    Lippuner, Kurt
    Univ Bern, Bern Univ Hosp, Dept Osteoporosis, Bern, Switzerland..
    McGuigan, Fiona E. A.
    Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Lund, Sweden..
    Mellstrom, Dan
    Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr,Geriatr Med, Gothenburg, Sweden.;Sahlgrenska Univ Hosp Mölndal, Geriatr Med, Mölndal, Sweden..
    Merlijn, Thomas
    Amsterdam UMC, Locat AMC, Amsterdam Publ Hlth Res Inst, Dept Gen Practice, Amsterdam, Netherlands..
    Nguyen, Tuan V.
    Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia.;Univ Technol Sydney, Sch Biomed Engn, Sydney, NSW, Australia.;UNSW Sydney, Sch Populat Hlth, UNSW Med, Kensington, NSW, Australia..
    Nordström, Anna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway; Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Östersund, Sweden.
    Nordström, Peter
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    O'Neill, Terence W.
    Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England.;Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England..
    Obermayer-Pietsch, Barbara
    Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria.;Ctr Biomarker Res Med, Graz, Austria..
    Ohlsson, Claes
    Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Osteoporosis Ctr, Dept Internal Med & Clin Nutr,Inst Med, Gothenburg, Sweden.;Reg Vastra Gotaland, Sahlgrenska Univ Hosp, Dept Drug Treatment, Gothenburg, Sweden..
    Orwoll, Eric S.
    Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA..
    Pasco, Julie A.
    Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia.;Barwon Hlth, Geelong, Vic, Australia.;Univ Melbourne, Dept Med Western Hlth, St Albans, Vic, Australia.;Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia..
    Rivadeneira, Fernando
    Erasmus MC, Dept Internal Med, Rotterdam, Netherlands..
    Schott, Anne-Marie
    Univ Claude Bernard Lyon 1, INSERM, U1290, RESHAPE, Lyon, France..
    Shiroma, Eric J.
    NIA, Lab Epidemiol & Populat Sci, Baltimore, MD 21224 USA..
    Siggeirsdottir, Kristin
    Iceland Heart Assoc, Kopavogur, Iceland.;Janus Rehabil, Reykjavik, Iceland..
    Simonsick, Eleanor M.
    NIA, Translat Gerontol Branch, Intramural Res Program, Baltimore, MD 21224 USA..
    Sornay-Rendu, Elisabeth
    Univ Claude Bernard Lyon1, Hop Edouard Herriot, INSERM, UMR 1033, Lyon, France..
    Sund, Reijo
    Univ Eastern Finland, Kuopio Musculoskeletal Res Unit, Kuopio, Finland..
    Swart, Karin M. A.
    Amsterdam UMC, Locat VUmc, Amsterdam Publ Hlth Res Inst, Dept Gen Practice, Amsterdam, Netherlands.;PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands..
    Szulc, Pawel
    Univ Claude Bernard Lyon1, Hop Edouard Herriot, INSERM, UMR 1033, Lyon, France..
    Tamaki, Junko
    Osaka Med & Pharmaceut Univ, Dept Hyg & Publ Hlth, Fac Med, Educ Fdn, Osaka, Japan..
    Torgerson, David J.
    Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England..
    van Schoor, Natasja M.
    Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Data Sci, Amsterdam, Netherlands..
    van Staa, Tjeerd P.
    Univ Manchester, Sch Hlth Sci, Ctr Hlth Informat, Fac Biol Med & Hlth, Manchester, Lancs, England..
    Vila, Joan
    Hosp del Mar Med Res Inst, Stat Support Unit, CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain..
    Wareham, Nicholas J.
    Univ Cambridge, MRC Epidemiol Unit, Cambridge, England..
    Wright, Nicole C.
    Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA..
    Yoshimura, Noriko
    Univ Tokyo Hosp, Dept Prevent Med Locomot Organ Disorders, Tokyo, Japan..
    Zillikens, MCarola
    Erasmus MC, Dept Internal Med, Rotterdam, Netherlands..
    Zwart, Marta
    PRECIOSA Fdn Invest, Barcelona, Spain.;Catalan Inst Hlth, Hlth Ctr Can Gibert del Pla, Girona, Spain.;Univ Girona, Dept Med Sci, Girona, Spain.;Inst Univ Invest Atencio Primaria Jordi Gol, Unitat Suport Recerca Girona, GROIMAP GROICAP Res Grp, Girona, Spain..
    Harvey, Nicholas C.
    Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England.;Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.;Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England..
    Lorentzon, Mattias
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia.;Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Osteoporosis Ctr, Dept Internal Med & Clin Nutr,Inst Med, Gothenburg, Sweden.;Reg Vastra Gotaland, Sahlgrenska Univ Hosp, Geriatr Med, Mölndal, Sweden..
    Leslie, William D.
    Univ Manitoba, Dept Med, Winnipeg, MB, Canada..
    Kanis, John A.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Vic, Australia.;Univ Sheffield, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England..
    A meta-analysis of previous falls and subsequent fracture risk in cohort studies2024In: Osteoporosis International, ISSN 0937-941X, E-ISSN 1433-2965, Vol. 35, no 3, p. 469-494Article in journal (Refereed)
    Abstract [en]

    Summary

    The relationship between self-reported falls and fracture risk was estimated in an international meta-analysis of individual-level data from 46 prospective cohorts. Previous falls were associated with an increased fracture risk in women and men and should be considered as an additional risk factor in the FRAX® algorithm.

    Introduction

    Previous falls are a well-documented risk factor for subsequent fracture but have not yet been incorporated into the FRAX algorithm. The aim of this study was to evaluate, in an international meta-analysis, the association between previous falls and subsequent fracture risk and its relation to sex, age, duration of follow-up, and bone mineral density (BMD).

    Methods

    The resource comprised 906,359 women and men (66.9% female) from 46 prospective cohorts. Previous falls were uniformly defined as any fall occurring during the previous year in 43 cohorts; the remaining three cohorts had a different question construct. The association between previous falls and fracture risk (any clinical fracture, osteoporotic fracture, major osteoporotic fracture, and hip fracture) was examined using an extension of the Poisson regression model in each cohort and each sex, followed by random-effects meta-analyses of the weighted beta coefficients.

    Results

    Falls in the past year were reported in 21.4% of individuals. During a follow-up of 9,102,207 person-years, 87,352 fractures occurred of which 19,509 were hip fractures. A previous fall was associated with a significantly increased risk of any clinical fracture both in women (hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.33–1.51) and men (HR 1.53, 95% CI 1.41–1.67). The HRs were of similar magnitude for osteoporotic, major osteoporotic fracture, and hip fracture. Sex significantly modified the association between previous fall and fracture risk, with predictive values being higher in men than in women (e.g., for major osteoporotic fracture, HR 1.53 (95% CI 1.27–1.84) in men vs. HR 1.32 (95% CI 1.20–1.45) in women, P for interaction = 0.013). The HRs associated with previous falls decreased with age in women and with duration of follow-up in men and women for most fracture outcomes. There was no evidence of an interaction between falls and BMD for fracture risk. Subsequent risk for a major osteoporotic fracture increased with each additional previous fall in women and men.

    Conclusions

    A previous self-reported fall confers an increased risk of fracture that is largely independent of BMD. Previous falls should be considered as an additional risk factor in future iterations of FRAX to improve fracture risk prediction.

1 - 11 of 11
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf